Vical and Baxter Sign Agreement for Hemophilia Gene Therapy

Vical Incorporated, based in San Diego, California, is focused on the development of
gene-based pharmaceutical products for human gene therapy. Vical's gene-based therapeutic
approach may offer safer and more cost-effective alternatives for the treatment and prevention
of many diseases, including infectious and cardiovascular diseases, autoimmune disorders and
cancer.
Baxter Healthcare Corporation is the principal domestic operating subsidiary of Baxter
International Inc. Through its subsidiaries, Baxter is the leading manufacturer and marketer of
healthcare products, systems and services worldwide. The Company offers more than 120,000
products to healthcare providers in 100 countries, and concentrates its research-and-development
programs in biotechnology, cardiovascular medicine, and renal therapy medical fields.